Compare · BLCO vs LUCY
BLCO vs LUCY
Side-by-side comparison of Bausch + Lomb Corporation (BLCO) and Innovative Eyewear Inc. (LUCY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLCO and LUCY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- BLCO is the larger of the two at $7.39B, about 1210.9x LUCY ($6.1M).
- BLCO has been more active in the news (11 items in the past 4 weeks vs 10 for LUCY).
- BLCO has more recent analyst coverage (22 ratings vs 0 for LUCY).
- Company
- Bausch + Lomb Corporation
- Innovative Eyewear Inc.
- Price
- -
- -
- Market cap
- $7.39B
- $6.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- 2022
- News (4w)
- 11
- 10
- Recent ratings
- 22
- 0
Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company in Canada and internationally. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that cover the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions. It offers intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
Latest BLCO
- Bausch + Lomb Reports Phase 2 Findings for BL1332 in Post-Surgical Ocular Pain
- SEC Form 144 filed by Bausch + Lomb Corporation
- SVP, Controller and CAO Munsch Frederick exercised 112,015 shares at a strike of $17.99 and sold $2,294,067 worth of shares (112,015 units at $20.48) (SEC Form 4)
- Director Robertson Russel C was granted 1,256 shares, increasing direct ownership by 1% to 95,516 units (SEC Form 4)
- Director Paulson John was granted 1,125 shares, increasing direct ownership by 1% to 90,948 units (SEC Form 4)
- Director Alfonso Eduardo was granted 1,125 shares, increasing direct ownership by 4% to 32,197 units (SEC Form 4)
- Bausch + Lomb downgraded by H.C. Wainwright with a new price target
- SEC Form 8-K filed by Bausch + Lomb Corporation
- SEC Form 10-Q filed by Bausch + Lomb Corporation
- SEC Form 8-K filed by Bausch + Lomb Corporation
Latest LUCY
- Innovative Eyewear's Lucyd Armor® Smart Safety Glasses Now Certified for Australia and New Zealand
- Innovative Eyewear Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear Reports Third-Quarter 2026 Results
- Chief Financial Officer Gayle Oswald was granted 60,000 shares, increasing direct ownership by 303% to 79,798 units (SEC Form 4)
- Chief AI & Growth Officer Dabrowski Konrad was granted 50,000 shares, increasing direct ownership by 122% to 90,977 units (SEC Form 4)
- Chief Operating Officer Abondano Joaquin was granted 90,000 shares, increasing direct ownership by 360% to 115,012 units (SEC Form 4)
- Chief Executive Officer Gross Harrison R. was granted 100,000 shares, increasing direct ownership by 284% to 135,195 units (SEC Form 4)
- Chief Technology Officer Cohen David Eric was granted 60,000 shares, increasing direct ownership by 254% to 83,622 units (SEC Form 4)